Tokyo, May 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061290) titled 'Prospective observational study on subcutaneous emphysema after robot-assisted radical prostatectomy' on May 18.
Study Type:
Observational
Primary Sponsor:
Institute - Kobe University
Condition:
Condition - Prostate cancer (Subcutaneous emphysema after robot-assisted laparoscopic radical prostatectomy)
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To characterize clinical features of subcutaneous emphysema after RARP and explore associated factors
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male
Key inclusion criteria - Prostate cancer patients scheduled for RARP at Kobe University Hospital or International Clinical Cancer Research Center, Kobe University Hospital; Age 20 years or older; Written informed consent obtained
Key exclusion criteria - Patients with pre-existing subcutaneous emphysema; Patients judged ineligible by the principal investigator
Target Size - 100
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 03 Month 31 Day
Anticipated trial start date - 2026 Year 06 Month 01 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070111
Disclaimer: Curated by HT Syndication.
